- Home
- VERB vs ATNF Comparison
VERB vs ATNF Comparison
Compare VERB & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERB
- ATNF
- Stock Information
- Founded
- VERB 2014
- ATNF 2016
- Country
- VERB United States
- ATNF United States
- Employees
- VERB N/A
- ATNF N/A
- Industry
- VERB Other Consumer Services
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- VERB Consumer Discretionary
- ATNF Health Care
- Exchange
- VERB Nasdaq
- ATNF Nasdaq
- Market Cap
- VERB 4.1M
- ATNF 4.1M
- IPO Year
- VERB N/A
- ATNF N/A
- Fundamental
- Price
- VERB $4.41
- ATNF $0.86
- Analyst Decision
- VERB Strong Buy
- ATNF
- Analyst Count
- VERB 1
- ATNF 0
- Target Price
- VERB $60.00
- ATNF N/A
- AVG Volume (30 Days)
- VERB 55.0K
- ATNF 136.6K
- Earning Date
- VERB 05-09-2025
- ATNF 05-14-2025
- Dividend Yield
- VERB N/A
- ATNF N/A
- EPS Growth
- VERB N/A
- ATNF N/A
- EPS
- VERB N/A
- ATNF N/A
- Revenue
- VERB $895,000.00
- ATNF N/A
- Revenue This Year
- VERB $36.76
- ATNF N/A
- Revenue Next Year
- VERB N/A
- ATNF N/A
- P/E Ratio
- VERB N/A
- ATNF N/A
- Revenue Growth
- VERB 1320.63
- ATNF N/A
- 52 Week Low
- VERB $3.81
- ATNF $0.66
- 52 Week High
- VERB $40.40
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- VERB 45.95
- ATNF 41.22
- Support Level
- VERB $3.82
- ATNF $0.80
- Resistance Level
- VERB $4.78
- ATNF $0.94
- Average True Range (ATR)
- VERB 0.44
- ATNF 0.11
- MACD
- VERB 0.04
- ATNF 0.02
- Stochastic Oscillator
- VERB 52.11
- ATNF 42.78
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.